Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase NA 19Phase 3 17Phase 1/2 4Phase 1 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 8CNS 7Sarcoma 4Breast 4Genitourinary 3Head & Neck 2Gynecologic 2

Conditions

Breast Neoplasms 4

Interventions

Trastuzumab 71Paclitaxel 63Cyclophosphamide 56pembrolizumab 53Fulvestrant 42Carboplatin 40Capecitabine 37Docetaxel 32Letrozole 27Doxorubicin 23palbociclib 21pertuzumab 19Nivolumab 18eribulin 17abemaciclib 17ribociclib 16Gemcitabine 16130-nm albumin-bound paclitaxel 16durvalumab 15Everolimus 15Albumin-Bound Paclitaxel 15sacituzumab govitecan 14Lapatinib 14Filgrastim 14fludarabine 13exemestane 13Taxes 13Bevacizumab 13Cisplatin 12olaparib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Surgical Procedures, Operative × Breast × Clear all
NCT02807597 2025-08-17

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

University of Texas Southwestern Medical Center

Phase 1/2 Terminated
9 enrolled 5 charts
Breast

Breast Neoplasms

NCT05981001 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Recruiting
170 enrolled
Breast

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Albert Einstein College of Medicine

Phase 1/2 Completed
55 enrolled 10 charts
Breast

Breast Neoplasms

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡